Bisphosphonates and avascular necrosis of the jaw: a possible association
- 18 April 2005
- journal article
- notable cases
- Published by AMPCo in The Medical Journal of Australia
- Vol. 182 (8) , 413-415
- https://doi.org/10.5694/j.1326-5377.2005.tb06761.x
Abstract
Click on the article title to read more.Keywords
This publication has 7 references indexed in Scilit:
- Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJournal of Oral and Maxillofacial Surgery, 2004
- Bisphosphonates and avascular necrosis of the jawsAustralian Prescriber, 2004
- New foundations in understanding osteonecrosis of the jawsJournal of Oral and Maxillofacial Surgery, 2004
- Osteonecrosis of the jaws associated with cancer chemotherapyJournal of Oral and Maxillofacial Surgery, 2003
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003
- Aetiology of bone disease and the role of bisphosphonates in multiple myelomaThe Lancet Oncology, 2003
- Heterocycle-Containing Bisphosphonates Cause Apoptosis and Inhibit Bone Resorption by Preventing Protein Prenylation: Evidence from Structure-Activity Relationships in J774 MacrophagesJournal of Bone and Mineral Research, 1998